SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXCH.L Regulatory News (XCH)

  • There is currently no data for XCH

Form 8.3 - Xchanging PLC

1 Dec 2015 14:58

RNS Number : 6131H
BlackRock Group
01 December 2015
Β 

ο»Ώ

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Xchanging PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

30 November 2015

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

5p ordinary

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,245,631

2.51%

0

0.00%

(2) Cash-settled derivatives:

Β 

0

0.00%

0

0.00%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

Β 

TOTAL:

6,245,631

2.51%

0

0.00%

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

5p ordinary

Sale

17,081

GBP 1.8077

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

No

Β 

Date of disclosure:

01 December 2015

Contact name:

Gareth Slade

Telephone number:

+44 20 7743 2536

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETEALAFESKSFFF
Date   Source Headline
7th Apr 20157:00 amRNSMM4 amendment to earn-out terms
1st Apr 20152:06 pmRNSBlocklisting Interim Review
31st Mar 20154:54 pmRNSTotal Voting Rights
27th Mar 201511:09 amRNSDirector/PDMR Shareholding
24th Mar 20157:03 amRNSCMA provisional clearance
18th Mar 201511:48 amRNSDirector/PDMR Shareholding
18th Mar 201511:45 amRNSDirector/PDMR Shareholding
16th Mar 20159:46 amRNSDirector/PDMR Shareholding
11th Mar 20153:07 pmRNSTotal Voting Rights
5th Mar 20154:57 pmRNSHolding(s) in Company
3rd Mar 201510:58 amRNSDirector/PDMR Shareholding
27th Feb 20155:27 pmRNSDirector Declaration
26th Feb 20157:01 amRNSAcquisition
26th Feb 20157:01 amRNSFinal Results
13th Feb 20157:00 amRNSHolding(s) in Company
6th Feb 20157:00 amRNSAcquisition of Spikes Cavell
3rd Feb 20157:00 amRNSBlocklisting Interim Review
3rd Feb 20157:00 amRNSHolding(s) in Company
30th Jan 201511:43 amRNSHolding(s) in Company
27th Jan 20156:28 pmRNSHolding(s) in Company
23rd Dec 20143:01 pmRNSDirector/PDMR Shareholding
19th Dec 20147:00 amRNSAcquisition of Total Objects completed
9th Dec 20143:09 pmRNSTotal Objects Acquisition to Complete
5th Dec 20144:03 pmRNSDirector/PDMR Shareholding
4th Dec 20147:00 amRNSAgencyport CMA Referral
3rd Dec 20141:48 pmRNSHolding(s) in Company
2nd Dec 20143:14 pmRNSAgencyport CMA Update
27th Nov 201410:51 amRNSDirector/PDMR Shareholding
27th Nov 20147:00 amRNSInvestor Seminar
26th Nov 201412:46 pmRNSTotal Voting Rights
21st Nov 20141:01 pmRNSDirector Declaration
14th Nov 20147:51 amRNSWorkers' Compensation contract
6th Nov 20147:00 amRNSInterim Management Statement
3rd Nov 20145:12 pmRNSBlocklisting Interim Review
20th Oct 20142:59 pmRNSDirector/PDMR Shareholding
3rd Oct 201412:20 pmRNSBlocklisting Interim Review
1st Oct 20147:00 amRNSAgencyport CMA Order
24th Sep 20144:36 pmRNSDirector/PDMR Shareholding
17th Sep 201410:30 amRNSHolding(s) in Company
17th Sep 201410:21 amRNSHolding(s) in Company
29th Aug 201411:11 amRNSDirector/PDMR Shareholding
12th Aug 20145:21 pmRNSTotal Voting Rights
1st Aug 20141:04 pmRNSBlocklisting Interim Review
31st Jul 20147:00 amRNSHalf Yearly Report
30th Jul 20147:00 amRNSTakes full ownership of Fondsdepot Bank
14th Jul 20145:31 pmRNSHolding(s) in Company
8th Jul 20147:00 amRNSMM4 amendment to earn-out terms
4th Jul 20147:00 amRNSAcquisition
3rd Jul 20147:00 amRNSAcquisition
24th Jun 20145:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.